Skip to main content Accessibility help
×
Home

Antibody-mediated encephalitis: a treatable cause of schizophrenia

  • Belinda R. Lennox (a1), Alasdair J. Coles (a2) and Angela Vincent (a3)

Summary

Psychiatrists need to be vigilant for the newly recognised and treatable disorder of antibody-mediated encephalitis. Psychiatric symptoms are common, and individuals with the disorder often present initially to psychiatric services. We describe the clinical features of the disorder and make recommendations for further investigations.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Antibody-mediated encephalitis: a treatable cause of schizophrenia
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Antibody-mediated encephalitis: a treatable cause of schizophrenia
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Antibody-mediated encephalitis: a treatable cause of schizophrenia
      Available formats
      ×

Copyright

Corresponding author

Belinda R. Lennox, DM, MRCPsych, Department of Psychiatry, University of Cambridge, Herchel Smith Building, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Email: bl224@cam.ac.uk

Footnotes

Hide All

Declaration of interest

A.J.C. reports receiving consulting fees, lecture fees and grant support from Genzyme. A.V. and the Nuffield Department of Clinical Neuroscicences/University of Oxford, hold patents, receive royalties from Athena Diagnostics and receive payments for antibody assays.

Footnotes

References

Hide All
1 Bullmore, E, Fletcher, P, Jones, PB. Why psychiatry can't afford to be neurophobic. Br J Psychiatry 2009; 194: 293–5.
2 Dalmau, J, Tüzün, E, Wu, HY, Masjuan, J, Rossi, JE, Voloschin, A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 2536.
3 Irani, SR, Bera, K, Waters, P, Zuliani, L, Maxwell, S, Zandi, MS, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133: 1655–67.
4 Dalmau, J, Lancaster, E, Martinez-Hernandez, E, Rosenfeld, M, Balice-Gordon, R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10: 6374.
5 Dalmau, J, Gleichman, AJ, Hughes, EG, Rossi, JE, Peng, X, Lai, M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091–8.
6 Vincent, A, Bien, CG, Irani, SR, Waters, P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011; 10: 759–72.
7 Vincent, A, Buckley, C, Schott, JM, Baker, I, Dewar, BK, Detert, N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004; 127: 701–12.
8 Parthasarathi, UD, Harrower, T, Tempest, M, Hodges, JR, Walsh, C, McKenna, PJ, et al. Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report. Br J Psychiatry 189: 182–3.
9 Zandi, MS, Irani, SR, Lang, B, Waters, P, Jones, PB, McKenna, P, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011; 258: 686–8.
10 Kraepelin, E. Dementia Praecox and Paraphrenia (ed. Robertson, G). Livingstone, 1919.
11 Pomarol-Clotet, E, Honey, GD, Murray, GK, Corlett, PR, Absalom, AR, Lee, M, et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry 2006; 189: 173–9.

Related content

Powered by UNSILO

Antibody-mediated encephalitis: a treatable cause of schizophrenia

  • Belinda R. Lennox (a1), Alasdair J. Coles (a2) and Angela Vincent (a3)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.